🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Diyarbakır
Clinical trial register · Turkey

Clinical Trials in Diyarbakır, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5432 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:51 UTC
5432
Studies in scope
all four open statuses
2496
Recruiting now
open to new participants
552
Lead sponsors
across recruiting studies
Top sites
Istanbul 2009 Ankara 1457 Izmir 568 Adana 378 Antalya 259
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital16 AstraZeneca11 Eli Lilly and Company10 Dicle University6 Hoffmann-La Roche6
Site location
Istanbul2009 Ankara1457 Izmir568 Adana378 Antalya259
All 319 locations
Target enrolment
to

Trials with a site in Diyarbakır

95 of 5432 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
ESPB Versus SPSIPB for Quality of Recovery After Video-Assisted Thoracoscopic Surgery
NCT07729488Postoperative Pain
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
128
Diyarbakır
2026-09-16
Not yet open
Diet and WB-EMS Effects in Obesity
NCT07562724Obesity & Overweight, Metabolic Disorders, Electrotherapy
Firat University
Not applicable
40
Diyarbakır, Elâzığ
2026-09-01
Not yet open
The Effect of Health Belief Model-Based Disaster Education for Parents of Children With Special Needs on General Disaster Preparedness Beliefs and Disaster Preparedness Levels
NCT07810608Disaster Preparedness, Health Education, Child With Special Health Care Needs, Parents Who Have Special Needs Children
Ataturk University
Not applicable
80
Diyarbakır
2026-09-01
Recruiting
Short-Axis Versus Long-Axis Ultrasound-Guided Radial Artery Cannulation
NCT07801807Radial Artery Cannulation
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
144
Diyarbakır
2026-08-25
Not yet open
Comparison of TAP Block and Umbilical Paramedian Linea Semilunaris Block in Pediatric Laparoscopic Surgery
NCT07801794Postoperative Pain, Opioid Consumption
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
56
Diyarbakır
2026-08-25
Not yet open
Inositol and Metformin Administration in Mediterranean Diet and Low-Carbohydrate Diets in Women With PCOS
NCT07770711PCOS (Polycystic Ovary Syndrome), Insulin Resistance, Obesity (BMI>30)
DrugMetformin
Dicle University
Not applicable
90
Diyarbakır
2026-08-20
Not yet open
Ovarian Stromal Stiffness and Ovarian Reserve Parameters Via Transvaginal Shear Wave Elastography
NCT07773337Ovarian Reserve Markers, Ovarian Function, Infertility, Anovulatory
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
100
Diyarbakır
2026-08
Not yet open
Turkish Chronic Total Occlusion Percutaneous Coronary Intervention Registry
NCT07761624Chronic Total Occlusion (CTO), Coronary Artery Disease
Ahmet Seyfeddin Gürbüz
Observational
70,000
Diyarbakır, Istanbul, Izmir, Konya, Malatya
2026-07-24
By invitation
Ultrasound Guidance vs. Landmark Technique for Catheter Malposition in IJV Catheterization
NCT07701720Catheter Malposition, Central Venous Catheterization
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Observational
204
Diyarbakır
2026-07-15
By invitation
Ultrasound Guidance vs Landmark Technique for Internal Jugular Vein Catheterization
NCT07701746Central Vein Catheter, Ultrasound
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Observational
144
Diyarbakır
2026-07-01
By invitation
Comparison of Erector Spinae Plane Block and Modified Pectoral Fascial Plane Block for Postoperative Analgesia in Pediatric Cardiac Surgery
NCT07740915Congenital Heart Disease, Postoperative Pain After Cardiac Surgery Via Median Sternotomy, Anesthesia
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
40
Diyarbakır
2026-06-30
Not yet open
Remifentanil Monotherapy vs. Remifentanil-Nicardipine for Controlled Hypotension in Otolaryngological Surgery
NCT07659496Otolaryngological Surgery, Anesthesia
DrugRemifentanil
Dicle University
Not applicable
60
Diyarbakır
2026-06-30
Not yet open
Cerebral Oximetry-Guided Low FiO2 Strategies in Thoracic Surgery.
NCT07659483Thoracic Surgery, Anesthesia
Dicle University
Not applicable
60
Diyarbakır
2026-06-15
Recruiting
Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in Mastectomy
NCT07579650Breast Cancer
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
50
Diyarbakır
2026-05-16
Recruiting
Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery
NCT07588230Heart Valve Disease, Postoperative Pain
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
90
Diyarbakır
2026-05-16
Recruiting
Intranasal Dexmedetomidine vs Oral Midazolam for Premedication in Pediatric Surgery
NCT07565116Pediatric Anesthesia, Preoperative Anxiety, Emergence Agitation
DrugsMidazolam·Dexmedetomidine
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
84
Diyarbakır
2026-05-05
Recruiting
Effect Of Specimen Extraction Site And Local Anesthesia On Postoperative Pain In Laparoscopic Appendectomy
NCT07824908Appendectomy, Laparoscopic, Appendicitis Acute, Pain Management
YUNUS YÜKSEL
Not applicable
300
Diyarbakır
2026-04-24
Not yet open
Serum Electrolytes and Contrast-Induced Nephropathy in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment
NCT07546448Acute Ischemic Stroke, Contrast-induced Nephropathy, Acute Kidney Injury
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Observational
250
Diyarbakır
2026-04-20
Recruiting
The Effect of a Kaleidoscope and Cartoons for Dental Treatment in Children
NCT07462364Dental Anxiety, Dental Fear, Pain
Dicle University
Not applicable
126
Diyarbakır
2026-03-10
Recruiting
HBV Reactivation in Immunocompromised Patients (REANT STUDY)
NCT07529171HBV
Yaşar Bayındır, MD
Observational
490
Adana, Ankara, Antalya, Diyarbakır, Düzce, Gaziantep, Istanbul, Izmir
2026-03-09
Recruiting
Effect of Preoperative CIMT on Hemodynamics During Liver Transplantation
NCT07660679Liver Transplantation, Carotid Intima-media Thickness
Dicle University
Observational
54
Diyarbakır
2026-02-11
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Istanbul, Üsküdar / İstanbul, Adana, Ankara, Diyarbakır, Gaziantep, Samsun
2026-01-06
Recruiting
Multimodal Fascial Plane Block for Postoperative Analgesia in Isolated CABG Surgery
NCT07587320Coronary Artery Bypass Graft (CABG), Postoperative Pain, Sternotomy
Saglik Bilimleri Universitesi
Not applicable
56
Diyarbakır
2026-01-01
Recruiting
Defining Ileorectal Syndrome: a Prospective Observational Study
NCT07385196Total Colectomy, Diarrhea, Urgency Incontinence, Soilings, Fecal
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Observational
30
Diyarbakır
2025-12-19
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Adana, Adapazarı, Ankara, Antalya, Diyarbakır, Edirne, Gaziantep, Istanbul
2025-12-12
Recruiting
Effect of Caudal Block on Urethrocutaneous Fistula After Distal Hypospadias Repair
NCT07675798Hypospadias, Caudal Block, Pediatric Anesthesia
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
80
Diyarbakır
2025-12-01
Recruiting
Comparison of Laryngeal Mask Airway Versus Endotracheal Intubation in Pediatric Laparoscopic Inguinal Hernia Repair
NCT07511764Inguinal Hernia Repair
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
266
Diyarbakır
2025-12-01
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Adana, Ankara, Antalya, Bornova, Diyarbakır, Edirne, Gaziantep, Pendik
2025-11-28
Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
NCT07088926Bronchiectasis With Pseudomonas Aeruginosa Colonization
DrugAZD0292
AstraZeneca
Phase 2
435
Adana, Ankara, Diyarbakır, Istanbul, Mersin, Zeytinburnu
2025-11-06
Not yet open
Pain and Anxiety in Pediatric Dentistry: Computer-Controlled vs. Traditional Anesthesia
NCT07156487Traditional Local Anesthesia, Computer-controlled Electronic Anesthesia, Dental Anxiety, Anxiety in Children
Dicle University
Not applicable
84
Diyarbakır
2025-10
Recruiting
TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%
NCT07279402NSCLC Stage IV, PD-L1 Gene Mutation, Atezolizumab, Real World Study
Antalya Training and Research Hospital
Observational
150
Adana, Afyonkarahisar, Ankara, Antalya, Aydin, Diyarbakır, Edirne, Gaziantep
2025-09-15
Recruiting
Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active Surveillance
NCT07168616Low Risk Prostate Cancer, Clinically Significant Prostate Cancer
Istanbul University - Cerrahpasa
Observational
201
Istanbul, Ankara, Diyarbakır, Gaziantep
2025-09-01
Recruiting
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
NCT07099898Neoplasms, Lung
DrugsRis-Rez·Topotecan
GlaxoSmithKline
Phase 3
420
Adana, Samsun, Ankara, Diyarbakır, Istanbul, Izmir
2025-08-11
Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
NCT06952803Prostate Cancer
DrugsPrednisolone/Prednisone·Saruparib·Abiraterone
AstraZeneca
Phase 3
700
Ankara, Cordaleo, Diyarbakır, Istanbul, Izmir, Sakarya, Seyhan, Şahinbey
2025-08-06
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT07062965Breast Cancer
DrugsPF-07248144·Exemestane·Everolimus·Fulvestrant
Pfizer
Phase 3
400
Istanbul, Ankara, Diyarbakır
2025-08-05
Recruiting
RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study
NCT07345247Liver Cancer, Adult
Ankara University
Observational
150
Adana, Ankara, Denizli, Diyarbakır, Istanbul, Izmir, Kayseri, Kocaeli
2025-08-01
Recruiting
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06757634Breast Cancer
DrugsGedatolisib·Ribociclib·Palbociclib·Letrozole
Celcuity Inc
Phase 3
1,180
Adana, Ankara, Diyarbakır, Edirne, Istanbul, İzmit, Konya, Mezitli
2025-07-24
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsSigvotatug vedotin·Pembrolizumab
Pfizer
Phase 3
714
Istanbul, Izmir, Ankara, Adana, Antalya, Diyarbakır, İstanbul - Fatih
2025-07-23
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
NCT07060807Breast Neoplasms
DrugsLiposomal doxorubicin·Patritumab deruxtecan·Xeloda·Abraxane
Merck Sharp & Dohme LLC
Phase 3
1,000
Adana, Ankara, Diyarbakır, Istanbul, Mersin, Rize, Samsun
2025-07-21
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
NCT06997497Colon Adenocarcinoma, Rectal Adenocarcinoma
DrugsBevacizumab biosimilar·Calderasib·Adrucil·Cetuximab
Merck Sharp & Dohme LLC
Phase 3
477
Sıhhiye, Adana, Ankara, Diyarbakır, Istanbul, Izmir
2025-07-16
Active, closed
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C
DrugsBemnifosbuvir-Ruzasvir·BEM/RZR·Sofosbuvir-Velpatasvir
Atea Pharmaceuticals, Inc.
Phase 3
880
Adana, Ankara, Bursa, Denizli, Diyarbakır, Istanbul, Kayseri, Samsun
2025-06-02
Recruiting
Impact of Intraoperative Hemodynamic Instability on Outcomes in Cardiac Surgery
NCT07324694Cardiac Surgery, Intraoperative Hemodynamic Instability, Postoperative Complication, Acute Kidney Injury
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Observational
230
Diyarbakır
2025-04-26
Recruiting
Comparison of Transvaginal Paracervical and Transperitoneal Approaches in Lymphadenectomy During v-NOTES Surgery for Patients Diagnosed With Endometrial Cancer
NCT06870903Endometrial Cancer, Lymphadenectomy, Sentinel Lymph Node Biopsy, Minimally Invasive Surgical Procedures
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Not applicable
52
Diyarbakır
2025-03-15
Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
NCT06764875HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
DrugsRilvegostomig·Trastuzumab deruxtecan·Adrucil·Trastuzumab
AstraZeneca
Phase 3
840
Ankara, Antalya, Diyarbakır, Erzurum, Istanbul, Izmir, Mezitli
2025-03-01
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
NCT06767514Non-Small Cell Lung Cancer
DrugsIvonescimab·Pembrolizumab
Summit Therapeutics
Phase 3
780
Istanbul, Ankara, Adana, Antalya, Diyarbakır, Gaziantep, Izmir, İzmit
2025-02-27
Recruiting
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
NCT06731478Gastric Cancer, Gastroesophageal Junction Cancer
DrugsTrastuzumab deruxtecan·Trastuzumab·Keytruda·Pembrolizumab
Daiichi Sankyo
Phase 3
726
Adana, Ankara, Diyarbakır, Erzurum, Istanbul, Izmir, Samsun
2025-02-27
Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
NCT06712316Non-small Cell Lung Cancer
DrugsPumitamig·Pemetrexed·Paclitaxel·Carboplatin
BioNTech SE
Phase 2/3
1,580
Adana, Ankara, Antalya, Diyarbakır, Gaziantep, Istanbul, Izmir, Kadıköy
2025-01-07
Active, closed
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
NCT06760637Breast Cancer
DrugsPF-07220060·Ribociclib·Abemaciclib·Palbociclib
Pfizer
Phase 3
1,035
Istanbul, Izmir, Adana, Ankara, Diyarbakır, Sakarya
2025-01-06
Recruiting
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
NCT06532006Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer, HER2-positive Gastric Cancer
DrugsHLX22·Trastuzumab·Capecitabine·Oxaliplatin
Shanghai Henlius Biotech
Phase 3
550
Adana, Ankara, Diyarbakır, Edirne, Erzurum, Kayseri, Kocaeli, Sakarya
2024-11-22
Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT06613698Liver Diseases, Alcoholic
DrugGSK4532990
GlaxoSmithKline
Phase 2
393
Kocaeli, Diyarbakır, Adana, Istanbul
2024-09-27
Recruiting
Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study
NCT06700174Atrial Septal Defect (ASD)
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
100
Ankara, Diyarbakır, Gaziantep, Istanbul, Izmir
2024-09-24
Recruiting
Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)
NCT07737340HIV Infections, Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH), Fatty Liver
Yaşar Bayındır, MD
Observational
411
Ankara, Adana, Antalya, Diyarbakır, Gaziantep, Istanbul, Izmir, Kocaeli
2024-06-01
Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT06203210Small Cell Lung Cancer
DrugsAmrubicin·Ifinatamab Deruxtecan·Lurbinectedin·Topotecan
Daiichi Sankyo
Phase 3
540
Ankara, Diyarbakır, Istanbul, Izmir
2024-05-21
Active, closed
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
NCT06356311Gastroesophageal Cancer
DrugsTrifluridine/Tipiracil·Sacituzumab tirumotecan·Irinotecan·Docetaxel
Merck Sharp & Dohme LLC
Phase 3
450
Adana, Ankara, Diyarbakır, Erzurum, Istanbul, Samsun, Van
2024-05-03
Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
NCT06357533Non-Small Cell Lung Cancer
DrugsRilvegostomig·Datopotamab Deruxtecan·Keytruda·Pembrolizumab
AstraZeneca
Phase 3
675
Adapazarı, Ankara, Antalya, Diyarbakır, Istanbul
2024-04-11
Active, closed
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
NCT06346392Gastric Cancer, Gastroesophageal Junction Cancer
DrugsSonesitatug Vedotin·Ramucirumab·Trifluridine/Tipiracil·Apatinib
AstraZeneca
Phase 3
594
Ankara, Diyarbakır, Erzurum, Istanbul
2024-03-04
Recruiting
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
NCT05827081Early Breast Cancer
DrugsLeuprolide·Goserelin·Exemestane·Ribociclib
Novartis Pharmaceuticals
Phase 3
1,400
Sakarya, Ankara, Istanbul, Izmir, Denizli, Antalya, Diyarbakır, Adana
2024-02-28
Active, closed
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
NCT06018337Metastatic Breast Cancer
DrugsDB-1303/BNT323·Nab-paclitaxel·Capecitabine·Paclitaxel
DualityBio Inc.
Phase 3
541
Adana, Ankara, Diyarbakır, Istanbul, Izmir, Mersin, Samsun
2024-01-18
Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
NCT06119581Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
DrugsOlomorasib·Pemetrexed·Cisplatin·Carboplatin
Eli Lilly and Company
Phase 3
1,264
Adana, Ankara, Antalya, Bursa, Diyarbakır, Istanbul, Izmir, Kocaeli
2023-12-21
Active, closed
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
NCT06097728Unresectable Pleural Mesothelioma
DrugsVolrustomig·Ipilimumab·Pemetrexed·Nivolumab
AstraZeneca
Phase 3
863
Ankara, Diyarbakır, Izmir
2023-11-09
Active, closed
A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.
NCT05984277Metastatic Non-small Cell Lung Cancer
DrugsVolrustomig·Pemetrexed·Paclitaxel·Carboplatin
AstraZeneca
Phase 3
895
Ankara, Antalya, Çankaya, Diyarbakır, Fatih-Istanbul, Istanbul, Izmir, Pamukkale
2023-10-24
Active, closed
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
NCT06037252Type 2 Diabetes, Obesity
DrugTirzepatide
Eli Lilly and Company
Phase 2
414
Kadıköy, Adana, Antalya, Bursa, Diyarbakır, Gaziantep, Istanbul, Samsun
2023-09-21
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
NCT05894239Metastatic Breast Cancer
DrugsPhesgo·Inavolisib
Hoffmann-La Roche
Phase 3
230
Adapazarı, Ankara, Bakirkoy / Istanbul, Diyarbakır, Istanbul, Izmir, Seyhan, Sihhiye/Ankara
2023-09-08
Recruiting
A Multicenter Selective Screening Study to Investigate the Frequency of Neuronal Ceroid Lipofuxinosis Type 2 (CLN2)
NCT06128226Neuronal Ceroid Lipofuxinosis Type2 (CLN2)
Nadir Hastalıkları Araştırma Derneği
Observational
750
Adana, Batman, Diyarbakır, Elâzığ, Gaziantep, Hatay, Kahramanmaraş, Malatya
2023-09-06
Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
NCT05646862Breast Cancer
DrugsBupropion·Omeprazole·Alpelisib·Inavolisib
Hoffmann-La Roche
Phase 3
420
Ankara, Diyarbakır, Edirne, Istanbul, Izmir, Kadiköy, Seyhan, Sihhiye/Ankara
2023-06-07
Active, closed
A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction
NCT07304843Primary Biliary Cholangitis (PBC)
Umecrine Cognition AB
Phase 1/2
84
Ankara, Balçova, Diyarbakır, Izmir, Kocaeli, Rize, Sanliurfa, Trabzon
2023-04-14
Active, closed
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer
DrugsDomvanalimab·Zimberelimab·Sacituzumab Govitecan·Nab-paclitaxel
Gilead Sciences
Phase 2
192
Adana, Ankara, Atakum, Diyarbakır, Konya, Meram Konya, Yenimahalle
2023-03-16
Active, closed
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034Ischemic Stroke; Ischemic Attack, Transient
DrugMilvexian
Janssen Research & Development, LLC
Phase 3
12,523
Ankara, Bursa, Diyarbakır, Elâzığ, Erciyes, Istanbul, Izmir, Konya
2023-02-15
Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200Atrial Fibrillation (AF)
DrugAbelacimab
Anthos Therapeutics, Inc.
Phase 3
2,500
Adana, Istanbul, Pendik, Izmir, Ankara, Antalya, Bursa, Diyarbakır
2022-12-27
Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
NCT05624450Viral Lung Infection and Acute Respiratory Failure
DrugTozorakimab
AstraZeneca
Phase 3
3,527
Ankara, Diyarbakır, Istanbul, Izmir, İzmit, Malatya, Ortahisar
2022-12-13
Active, closed
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.
NCT05445843Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
DrugJDQ443
Novartis Pharmaceuticals
Phase 2
95
Istanbul, Diyarbakır, Ankara
2022-12-06
Active, closed
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
NCT05514054Breast Neoplasms
DrugsImlunestrant·Tamoxifen·Exemestane·Anastrozole
Eli Lilly and Company
Phase 3
8,000
Adana, Adapazarı, Altindağ, Ankara, Antalya, Bursa, Diyarbakır, Edirne
2022-10-04
Active, closed
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma
NCT05409066Follicular Lymphoma (FL)
DrugsEpcoritamab·Lenalidomide·Rituximab
Genmab
Phase 3
549
Ankara, Antalya, Diyarbakır, Istanbul, Izmir, Kocaeli, Samsun
2022-09-20
Active, closed
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
NCT05296798Locally Advanced or Metastatic Breast Cancer
DrugsPhesgo·Giredestrant·Docetaxel·Paclitaxel
Hoffmann-La Roche
Phase 3
922
Adana, Ankara, Diyarbakır, Edirne, Erzurum, Istanbul, Izmir, İzmit
2022-07-18
Active, closed
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
NCT05352672Melanoma
DrugsFianlimab·Cemiplimab·Pembrolizumab
Regeneron Pharmaceuticals
Phase 3
1,546
Yüreğir, Istanbul, Izmir, İzmit, Gaziantep, Ankara, Diyarbakır, Edirne
2022-07-14
Active, closed
Roll-over Study to Allow Continued Access to Ribociclib
NCT05161195Metastatic Breast Cancer
DrugsGoserelin·Tamoxifen·Anastrozole·Ribociclib
Novartis Pharmaceuticals
Phase 4
134
Malatya, Diyarbakır, Izmir, Kecioren Ankara
2022-07-07
Active, closed
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)
NCT05374512Breast Cancer
DrugsEribulin·Datopotamab Deruxtecan·Nab-paclitaxel·Capecitabine
AstraZeneca
Phase 3
644
Ankara, Diyarbakır, Istanbul, Izmir, Konya, Malatya
2022-05-16
Active, closed
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
NCT05288166Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs
DrugsAbiraterone·Prednisolone·Abemaciclib·Prednisone
Eli Lilly and Company
Phase 3
925
Stanbul, Izmir, Karsiyaka, Adana, Ankara, Diyarbakır, Edirne, Istanbul, Malatya
2022-04-14
Active, closed
Olorofim Aspergillus Infection Study
NCT05101187Invasive Aspergillosis
DrugAmbisome
F2G Biotech GmbH
Phase 3
225
Ankara, Diyarbakır, Istanbul, Izmir, Samsun
2022-03-31
Recruiting
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
NCT04928846Non Small Cell Lung Cancer
DrugsTelisotuzumab vedotin·Docetaxel
AbbVie
Phase 3
768
Çankaya, Cordaleo, Adana, Ankara, Battalgazi/malatya, Bursa, Diyarbakır, Istanbul
2022-03-25
Active, closed
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
NCT05169567Breast Neoplasm, Neoplasm Metastasis
DrugsAbemaciclib·Fulvestrant
Eli Lilly and Company
Phase 3
368
Cordaleo, Meram, Adana, Ankara, Diyarbakır, Edirne, Istanbul, Malatya
2022-03-11
Recruiting
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
NCT05329350Muscular Ventricular Septal Defect
Occlutech International AB
Observational
50
Izmir, Eskişehir, Diyarbakır, Gaziantep
2022-03-03
Active, closed
A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer
NCT05221840Non-Small Cell Lung Cancer
DrugsMonalizumab·Oleclumab·Durvalumab
AstraZeneca
Phase 3
1,051
Ankara, Cordaleo, Diyarbakır, Goztepe Istanbul
2022-02-07
Recruiting
Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects
NCT05264753Patent Ductus Arteriosus
Occlutech International AB
Observational
255
Aydin, Eskişehir, Adana, Diyarbakır
2021-12-20
Active, closed
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT04819100Carcinoma, Non-Small-Cell Lung
DrugSelpercatinib
Eli Lilly and Company
Phase 3
152
Bornova, Izmir, Karsiyaka, Adana, Ankara, Antalya, Bursa, Diyarbakır, Edirne
2021-12-20
Active, closed
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
NCT05091567Small-Cell Lung Cancer
DrugsLurbinectedin·Tecentriq·Etoposide·Atezolizumab
Hoffmann-La Roche
Phase 3
660
Ankara, Bursa, Denizli, Diyarbakır, Edirne, Istanbul, Izmir, İzmit
2021-11-18
Recruiting
ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices
NCT05174442Heart Diseases
Occlutech International AB
Observational
685
Adana, Malatya, Izmir, Aydin, Istanbul, Antalya, Karaman, Diyarbakır
2021-10-14
Active, closed
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
NCT04975308Breast Neoplasms, Neoplasm Metastasis
DrugsImlunestrant·Exemestane·Abemaciclib·Fulvestrant
Eli Lilly and Company
Phase 3
874
Stanbul, Üsküdar / Stanbul, Adana, Ankara, Antalya, Diyarbakır, Edirne, Istanbul
2021-10-04
Active, closed
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
NCT04873362Breast Cancer
DrugsTrastuzumab emtansine·Herceptin·Tecentriq·Trastuzumab
Hoffmann-La Roche
Phase 3
1,188
Adana, Ankara, Antalya, Bornova, ?zm?r, Diyarbakır, Edirne, Istanbul, Izmir
2021-05-04
Active, closed
Inflammatory Indices, Early Mortality, and ICU Stay in Geriatric PFN Patients
NCT07607886Intertrochanteric Femur Fracture, Hip Fracture Surgeries, Geriatric Anesthesia
Saglik Bilimleri Universitesi
Observational
233
Diyarbakır
2021-01-01
Active, closed
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
NCT04576455Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
DrugsGiredestrant·Fulvestrant
Hoffmann-La Roche
Phase 2
303
Ankara, Antalya, Diyarbakır, Istanbul, Izmir, Samsun
2020-11-27
Active, closed
Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC
NCT04550260Esophageal Squamous Cell Carcinoma
DrugsFluorouracil·Durvalumab·Capecitabine·Cisplatin
AstraZeneca
Phase 3
640
Ankara, Diyarbakır, Erzurum, Goztepe Istanbul, Izmir, Van
2020-10-19
Active, closed
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
NCT04194944Non-Small Cell Lung Cancer
DrugsSelpercatinib·Pemetrexed·Cisplatin·Carboplatin
Eli Lilly and Company
Phase 3
261
Bornova, Adana, Ankara, Antalya, Diyarbakır, Edirne, Istanbul, Izmir
2020-02-17
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
DrugsZolbetuximab·Nab-paclitaxel·Gemcitabine
Astellas Pharma Global Development, Inc.
Phase 2
393
Ankara, Diyarbakır, Istanbul, Konya
2019-03-15
Active, closed
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
NCT03547973Metastatic Urothelial Cancer
DrugsDomvanalimab·Zimberelimab·Avelumab·Enfortumab Vedotin
Gilead Sciences
Phase 2
502
Ankara, Diyarbakır, Edrine, Istanbul, Izmir, Seyhan
2018-08-13
Rows per page Showing 1–95 of 95
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-turkey/city/diyarbak-r

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,432 studies in total at the last sync on 26 Sep 2026, 19:51 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 95 of those studies with a site in Diyarbakır.

How many clinical trials are recruiting in Diyarbakır?

50 of the 95 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:51 UTC sync. A further 10 have not yet opened recruitment, 32 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Diyarbakır), 95 studies
PhaseStudiesRecruitingShare
Phase 3452247.4%
Not applicable201121.1%
Observational181318.9%
Phase 2939.5%
Phase 1/2101.1%
Phase 2/3111.1%
Phase 4101.1%

Most active sponsors

Lead sponsors with the most studies (Diyarbakır)
Lead sponsorStudiesRecruiting
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital1610
AstraZeneca115
Eli Lilly and Company103
Dicle University62
Hoffmann-La Roche62
Pfizer43
Merck Sharp & Dohme LLC32
Novartis Pharmaceuticals31
Occlutech International AB33
Daiichi Sankyo22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.